PFE vs LLY
Pfizer Inc. vs Eli Lilly and Company — AI-powered side-by-side comparison
| Metric | PFE | LLY |
|---|---|---|
| AI Score | 47 | 61 |
| Price | $24.04 | $1,216.24 |
| P/E Ratio | 18.29× | 45.75× |
| ROE | 8.4% | 101.3% |
| Revenue Growth YoY | 1.4% | 47.4% |
| Gross Margin | 74.8% | 82.8% |
| Debt / Equity | 0.75× | 1.60× |
| Dividend Yield | 7.1% | 0.6% |
| RSI (14) | 46.1 | 69.6 |
| Beta | 0.2848 | 0.5016 |
| Expected Upside | +7.2% | — |
Want the full breakdown?
Committee votes, technicals, and trade plans for both companies.
PFE Full Analysis
LLY Full Analysis